通过p53的转录激活与抑制生长相关,但不与转化相关
T Crook1, N J Marston, E A Sara
1Ludwig Institute for Cancer Research, St. Mary's Hospital Medical School, London, England.
Cell
|December 2, 1994
概括
突变瘤抑制蛋白p53 (p53) 可能会失去抑制瘤的能力. 虽然一些p53突变激活转录并抑制生长,但其他可以促进转化,表明转录活动并不总是确保瘤抑制.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 瘤抑制基因的基因
背景情况:
- 瘤抑制蛋白p53对于预防癌症至关重要.
- 在各种癌症中,p53的突变很常见,导致其瘤抑制功能丧失.
- 了解p53突变的功能后果对于癌症治疗至关重要.
研究的目的:
- 为了研究转录激活和p53突变体的生长/转化抑制之间的相关性.
- 为了确定所有转录活跃的p53突变是否可以抑制瘤形成.
- 探索某些p53突变可能促进转变的机制.
主要方法:
- 在p53-null人类细胞中对大量p53突变的分析.
- 评估p53突变的转录激活和生长抑制功能.
- 在初级动物细胞中评估转化抑制.
- 研究突变p53.3突变体对跨主导抑制的作用.
主要成果:
- 在p53-null人类细胞中,转录激活和生长抑制之间观察到强烈的相关性.
- 并非所有转录活跃的p53突变物都保留了抑制初级动物细胞转化的能力.
- 两种特定的瘤衍生的p53突变体表现出转化和交换活动.
- 这些突变的转化独立于内源性p53功能的转主抑制,观察到高的p53转录活性.
结论:
- 通过p53突变的转录激活并不总是导致瘤抑制.
- 尽管保留了转录活性,但某些p53突变可能具有致癌潜力.
- 这些发现突显了p53突变在癌症发展和进展中的复杂作用.
相关概念视频
Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


